PTSD: from neurobiology to pharmacological treatments

European Journal of Psychotraumatology

Volumn 7, Issue 1, 2016, Pages

  Kelmendi, Benjamin ^a,b   Adams, Thomas G ^a,b   Yarnell, Stephanie ^a   Southwick, Steven ^a,b   Abdallah, Chadi G ^a,b   Krystal, John H ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c Yale University School of Medicine   (United States)

Author keywords

cannabinoid; GABA; glutamate; ketamine; noradrenergic; pharmacology; PTSD; serotonin

Indexed keywords

EID: 85012026954     PISSN: 20008198     EISSN: 20008066     Source Type: Journal    
DOI: 10.3402/EJPT.V7.31858     Document Type: Article

References (102)

1. Abdallah, C.G., Sanacora, G., Duman, R.S., & Krystal, J.H. (2015). Ketamine and rapid-acting antidepressants: A window into a new neurobiology for mood disorder therapeutics. Annual Review of Medicine, 66, 509-523. doi: http://dx.doi.org/10. 1146/annurev-med-053013-062946
2. Alexander, B., Lund, B.C., Bernardy, N.C., Christopher, M.L., & Friedman, M.J. (2015). Early discontinuation and suboptimal dosing of prazosin: A potential missed opportunity for veterans with posttraumatic stress disorder. Journal of Clinical Psychiatry, 76(5), e639-e644. doi: http://dx.doi.org/10.4088/JCP.14m09057
3. Alexander, W. (2012). Pharmacotherapy for posttraumatic stress disorder in combat veterans: Focus on antidepressants and atypical antipsychotic agents. P T, 37(1), 32-38.
4. Atsak, P., Roozendaal, B., & Campolongo, P. (2012). Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience, 204, 104-116. doi: http://dx.doi.org/10.1016/j.neuroscience.2011.08.047
5. Attari, A., Rajabi, F., & Maracy, M.R. (2014). D-cycloserine for treatment of numbing and avoidance in chronic posttraumatic stress disorder: A randomized, double blind, clinical trial. Journal of Research in Medical Sciences, 19(7), 592-598.
6. Bailey, C.R., Cordell, E., Sobin, S.M., & Neumeister, A. (2013). Recent progress in understanding the pathophysiology of posttraumatic stress disorder: Implications for targeted pharmacological treatment. CNS Drugs, 27(3), 221-232. doi: http://dx.doi.org/10.1007/s40263-013-0051-4
7. Benedek, D.M., Friedman, M.J., Zatzick, D., & Ursano, R.J. (2009). Guideline watch (March 2009): Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Journal of Lifelong Learning, 7, 204-2013.
8. Berger, W., Mendlowicz, M.V., Marques-Portella, C., Kinrys, G., Fontenelle, L.F., Marmar, C.R., … Figueira, I. (2009). Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review. Progress in Neuro-psychopharmacology. Biological Psychiatry, 33(2), 169-180. doi: http://dx.doi.org/10.1007/10.1016/j.pnpbp.2008.12.004
9. Berman, R.M., Cappiello, A., Anand, A., Oren, D.A., Heninger, G.R., Charney, D.S., … Krystal, J.H. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47(4), 351-354.
10. Bonn-Miller, M.O., Boden, M.T., Bucossi, M.M., & Babson, K.A. (2014). Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. American Journal of Drug and Alcohol Abuse, 40(1), 23-30. doi: http://dx.doi.org/10.1007/10.3109/00952990.2013.821477
11. Bonn-Miller, M.O., Vujanovic, A.A., Feldner, M.T., Bernstein, A., & Zvolensky, M.J. (2007). Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users. Journal of Traumatic Stress, 20(4), 577-586. doi: http://dx.doi.org/10.1007/10.1002/jts.20243
12. Brady, K., Pearlstein, T., Asnis, G.M., Baker, D., Rothbaum, B., Sikes, C.R., … Farfel, G.M. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. Journal of the American Medical Association, 283(14), 1837-1844.
13. Bremner, J.D., Southwick, S.M., Darnell, A., & Charney, D.S. (1996). Chronic PTSD in Vietnam combat veterans: Course of illness and substance abuse. American Journal of Psychiatry, 153(3), 369-375. doi: http://dx.doi.org/10.1007/10.1176/ajp.153. 3.369
14. Bryant, R.A., Creamer, M., O’Donnell, M., Silove, D., & McFarlane, A.C. (2009). A study of the protective function of acute morphine administration on subsequent posttraumatic stress disorder. Biological Psychiatry, 65(5), 438-440. doi: http://dx. doi.org/10.1007/10.1016/j.biopsych.2008.10.032
15. Campolongo, P., Roozendaal, B., Trezza, V., Hauer, D., Schelling, G., McGaugh, J.L., … Cuomo, V. (2009). Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proceedings of the National Academy Sciences USA, 106(12), 4888-4893. doi: http://dx.doi.org/10.1007/10.1073/pnas.0900835106
16. Chambers, R.A., Bremner, J.D., Moghaddam, B., Southwick, S.M., Charney, D.S., & Krystal, J.H. (1999). Glutamate and posttraumatic stress disorder: Toward a psychobiology of dissociation. Seminars in Clinical Neuropsychiatry, 4(4), 274-281. doi: http://dx.doi.org/10.1007/10.153/SCNP00400274
17. Charney, D.S. (2004). Psychobiological mechanisms of resilience and vulnerability: Implications for successful adaptation to extreme stress. American Journal of Psychiatry, 161(2), 195-216. doi: http://dx.doi.org/10.1007/10.1176/appi.ajp.161.2.195
18. Chhatwal, J.P., Davis, M., Maguschak, K.A., & Ressler, K.J. (2005). Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology, 30(3), 516-524. doi: http://dx.doi.org/10.1007/10.1038/sj.npp.1300655
19. Corcoran, K.A., & Maren, S. (2001). Hippocampal inactivation disrupts contextual retrieval of fear memory after extinction. The Journal of Neuroscience, 21(5), 1720-1726.
20. D’Andrea, D., & Andrew Sewell, R. (2013). Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion. Biological Psychiatry, 74(9), e13-14. doi: http://dx.doi.org/10.1007/10.1016/j.biopsych.2013.04.019
21. D’Souza, D.C., Gil, R.B., Zuzarte, E., MacDougall, L.M., Donahue, L., Ebersole, J.S., … Krystal, J H. (2006). Gamma-Aminobutyric acid-serotonin interactions in healthy men: Implications for network models of psychosis and dissociation. Biological Psychiatry, 59(2), 128-137. doi: http://dx.doi.org/10.1007/10. 1016/j.biopsych.2005.06.020
22. Davidson, J., Baldwin, D., Stein, D.J., Kuper, E., Benattia, I., Ahmed, S., … Musgnung, J. (2006). Treatment of posttraumatic stress disorder with venlafaxine extended release: A 6-month randomized controlled trial. Archives of General Psychiatry, 63(10), 1158-1165. doi: http://dx.doi.org/10.1007/10.1001/archpsyc.63.10.1158
23. Davidson, J.R., Brady, K., Mellman, T.A., Stein, M.B., & Pollack, M.H. (2007). The efficacy and tolerability of tiagabine in adult patients with posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 27(1), 85-88. doi: http://dx.doi.org/10. 1007/10.1097/JCP.0b013e31802e5115
24. Davidson, J.R., Rothbaum, B.O., van der Kolk, B.A., Sikes, C.R., & Farfel, G.M. (2001). Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Archives of General Psychiatry, 58(5), 485-492.
25. de Kleine, R.A., Hendriks, G.J., Kusters, W.J., Broekman, T.G., & van Minnen, A. (2012). A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biological Psychiatry, 71(11), 962-968. doi: http://dx.doi.org/10.1007/10.1016/j.biopsych.2012.02.033
26. Del Arco, A., & Mora, F. (2009). Neurotransmitters and prefrontal cortex-limbic system interactions: Implications for plasticity and psychiatric disorders. Journal of Neural Transmission (Vienna), 116(8), 941-952. doi: http://dx.doi.org/10.1007/10. 1007/s00702-009-0243-8
27. Difede, J., Cukor, J., Wyka, K., Olden, M., Hoffman, H., Lee, F.S., …Altemus, M. (2014). D-cycloserine augmentation of exposure therapy for posttraumatic stress disorder: A pilot randomized clinical trial. Neuropsychopharmacology, 39(5), 1052-1058. doi: http://dx.doi.org/10.1007/10.1038/npp.2013.317
28. Feder, A., Parides, M.K., Murrough, J.W., Perez, A.M., Morgan, J.E., Saxena, S., … Charney, D.S. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. Journal of the American Medical Association Psychiatry, 71(6), 681-688. doi: http://dx. doi.org/10.1007/10.1001/jamapsychiatry.2014.62
29. Feldman, R., Vengrober, A., & Ebstein, R.P. (2014). Affiliation buffers stress: Cumulative genetic risk in oxytocin-vasopressin genes combines with early caregiving to predict PTSD in warexposed young children. Translational Psychiatry, 4, e370. doi: http://dx.doi.org/10.1007/10.1038/tp.2014.6
30. Frank, J.B., Kosten, T.R., Giller, E.L., Jr, & Dan, E. (1988). A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. American Journal of Psychiatry, 145(10), 1289-1291. doi: http://dx.doi.org/10.1007/10.1176/ajp. 145.10.1289
31. Friedman, M.J., Marmar, C.R., Baker, D.G., Sikes, C.R., & Farfel, G.M. (2007). Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. Journal of Clinical Psychiatry, 68(5), 711-720.
32. Glass, M., Dragunow, M., & Faull, R.L. (1997). Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 77(2), 299-318.
33. Greer, G.R., Grob, C.S., & Halberstadt, A.L. (2014). PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program. Journal of Psychoactive Drugs, 46(1), 73-77. doi: http://dx.doi.org/10.1007/10.1080/02791072. 2013.873843
34. Gunduz-Cinar, O., MacPherson, K.P., Cinar, R., Gamble-George, J., Sugden, K., Williams, B., … Holmes, A. (2013). Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Molecular Psychiatry, 18(7), 813-823. doi: http://dx.doi.org/10.1007/10.1038/mp.2012.72
35. Haller, J., Bakos, N., Szirmay, M., Ledent, C., & Freund, T.F. (2002). The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. European Journal of Neuroscience, 16(7), 1395-1398.
36. Haller, J., Varga, B., Ledent, C., & Freund, T.F. (2004). CB1 cannabinoid receptors mediate anxiolytic effects: Convergent genetic and pharmacological evidence with CB1-specific agents. Behavioral Pharmacology, 15(4), 299-304.
37. Hamner, M.B., Faldowski, R.A., Robert, S., Ulmer, H.G., Horner, M.D., & Lorberbaum, J.P. (2009). A preliminary controlled trial of divalproex in posttraumatic stress disorder. Annual Clinical Psychiatry, 21(2), 89-94.
38. Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological Psychiatry, 54(12), 1389-1398.
39. Heresco-Levy, U., Kremer, I., Javitt, D.C., Goichman, R., Reshef, A., Blanaru, M., … Cohen, T. (2002). Pilot-controlled trial of D-cycloserine for the treatment of posttraumatic stress disorder. International Journal of Neuropsychopharmacology, 5(4), 301-307. doi: http://dx.doi.org/10.1007/10.1017/S1461145702 003061
40. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R., … Rice, K.C. (1990). Cannabinoid receptor localization in brain. Proceedings of National Academy of Sciences USA, 87(5), 1932-1936.
41. Hill, M.N., & McEwen, B.S. (2009). Endocannabinoids: The silent partner of glucocorticoids in the synapse. Proceedings of National Academy of Sciences USA, 106(12), 4579-4580. doi: http://dx.doi.org/10.1007/10.1073/pnas.0901519106
42. Hysek, C.M., Simmler, L.D., Ineichen, M., Grouzmann, E., Hoener, M.C., Brenneisen, R., … Liechti, M.E. (2011). The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (‘‘ecstasy’’) in humans. Clinical Pharmacology and Therapeutics, 90(2), 246-255. doi: http://dx.doi.org/10. 1007/10.1038/clpt.2011.78
43. Koch, S.B., van Zuiden, M., Nawijn, L., Frijling, J.L., Veltman, D.J., & Olff, M. (2014). Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: Salience processing and fear inhibition processes. Psychoneuroendocrinology, 40, 242-256. doi: http://dx.doi.org/10.1007/10.1016/j.psyneuen. 2013.11.018
44. Koch, S.B., van Zuiden, M., Nawijn, L., Frijling, J.L., Veltman, D.J., & Olff, M. (2016). Intranasal oxytocin normalizes amygdala functional connectivity in posttraumatic stress disorder. Neuropsychopharmacology. 41(8), 20141-51 doi: http://dx.doi. org/10.1007/10.1038/npp.2016.1
45. Krystal, J.H., & Neumeister, A. (2009). Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Research, 1293, 13-23. doi: http://dx.doi.org/10.1007/10.1016/j.brainres.2009.03.044
46. Krystal, J.H., Webb, E., Cooney, N.L., Kranzler, H.R., Southwick, S.W., Heninger, G.R., … Charney, D.S. (1996). Serotonergic and noradrenergic dysregulation in alcoholism: mchlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. American Journal of Psychiatry, 153(1), 83-92.
47. LeDoux, J.E. (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23, 155-184. doi: http://dx.doi.org/10.1007/10. 1146/annurev.neuro.23.1.155
48. Leweke, F.M., & Koethe, D. (2008). Cannabis and psychiatric disorders: It is not only addiction. Addiction Biology, 13(2), 264-275. doi: http://dx.doi.org/10.1007/10.1111/j.1369-1600. 2008.00106.x
49. Liechti, M.E., & Vollenweider, F.X. (2001). Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Human Psychopharmacology, 16(8), 589-598. doi: http://dx.doi.org/10.1007/10.1002/hup.348
50. Litz, B.T., Salters-Pedneault, K., Steenkamp, M.M., Hermos, J.A., Bryant, R.A., Otto, M.W., … Hofmann, S.G. (2012). A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research, 46(9), 1184-1190. doi: http://dx.doi.org/10.1007/10.1016/j.jpsychires.2012.05.006
51. Lund, B.C., Bernardy, N.C., Alexander, B., & Friedman, M.J. (2012). Declining benzodiazepine use in veterans with posttraumatic stress disorder. Journal of Clinical Psychiatry, 73(3), 292-296. doi: http://dx.doi.org/10.1007/10.4088/JCP.10m06775
52. Lutz, B. (2007). The endocannabinoid system and extinction learning. Molecular Neurobiology, 36(1), 92-101. doi: http://dx.doi.org/10.1007/10.1007/s12035-007-8004-x
53. Marshall, R.D., Beebe, K.L., Oldham, M., & Zaninelli, R. (2001). Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study. American Journal of Psychiatry, 158(12), 1982-1988. doi: http://dx.doi.org/10.1007/10.1176/appi.ajp.158.12.1982
54. Marsicano, G., Wotjak, C.T., Azad, S.C., Bisogno, T., Rammes, G., Cascio, M.G., … Lutz, B. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature, 418(6897), 530-534. doi: http://dx.doi.org/10.1007/10.1038/nature00839
55. McGhee, L.L., Maani, C.V., Garza, T.H., Gaylord, K.M., & Black, I.H. (2008). The correlation between ketamine and posttraumatic stress disorder in burned service members. The Journal of Trauma, 64(2 Suppl), S195-198; Discussion S197-198. doi: http://dx.doi.org/10.1007/10.1097/TA.0b013e318160ba1d
56. Meyerhoff, D.J., Mon, A., Metzler, T., & Neylan, T.C. (2014). Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality. Sleep, 37(5), 893-900. doi: http://dx.doi.org/10. 1007/10.5665/sleep.3654
57. Mithoefer, M.C., Wagner, M.T., Mithoefer, A.T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of {+/ +} 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439-452. doi: http://dx.doi.org/10.1007/10.1177/0269881110378371
58. Mithoefer, M.C., Wagner, M.T., Mithoefer, A.T., Jerome, L., Martin, S.F., Yazar-Klosinski, B., … Doblin, R. (2013). Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective long-term follow-up study. Journal of Psychopharmacology, 27(1), 28-39. doi: http://dx.doi.org/10. 1007/10.1177/0269881112456611
59. Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997). Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. Journal of Neuroscience, 17(8), 2921-2927.
60. Morgan, C.A., 3rd, Rasmusson, A.M., Wang, S., Hoyt, G., Hauger, R.L., & Hazlett, G. (2002). Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: Replication and extension of previous report. Biological Psychiatry, 52(2), 136-142.
61. Morgan, C.A., 3rd, Wang, S., Southwick, S.M., Rasmusson, A., Hazlett, G., Hauger, R.L., … Charney, D.S. (2000). Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biological Psychiatry, 47(10), 902-909.
62. Murrough, J.W., Czermak, C., Henry, S., Nabulsi, N., Gallezot, J.D., Gueorguieva, R., … Neumeister, A. (2011). The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding. Archives of General Psychiatry, 68(9), 892-900. doi: http://dx.doi.org/10. 1007/10.1001/archgenpsychiatry.2011.91
63. Neumeister, A. (2013). The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD. Depression and Anxiety, 30(2), 93-96. doi: http://dx.doi.org/10. 1007/10.1002/da.22031
64. Neumeister, A., Normandin, M.D., Pietrzak, R.H., Piomelli, D., Zheng, M.Q., Gujarro-Anton, A., … Huang, Y. (2013). Elevated brain cannabinoid CB1 receptor availability in posttraumatic stress disorder: A positron emission tomography study. Molecular Psychiatry, 18(9), 1034-1040. doi: http://dx. doi.org/10.1007/10.1038/mp.2013.61
65. Neumeister, A., Seidel, J., Ragen, B.J., & Pietrzak, R.H. (2015). Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder. Psychoneuroendocrinology, 51, 577-584. doi: http://dx.doi.org/10.1007/10.1016/j.psyneuen.2014.10.012
66. Nishi, D., Hashimoto, K., Noguchi, H., Hamazaki, K., Hamazaki, T., & Matsuoka, Y. (2015). Glutamatergic system abnormalities in posttraumatic stress disorder. Psychopharmacology (Berl), 232(23), 4261-4268. doi: http://dx.doi.org/10.1007/10. 1007/s00213-015-4052-5
67. O’Donnell, T., Hegadoren, K.M., & Coupland, N.C. (2004). Noradrenergic mechanisms in the pathophysiology of posttraumatic stress disorder. Neuropsychobiology, 50(4), 273-283. doi: http://dx.doi.org/10.1007/10.1159/000080952
68. Olff, M., Koch, S.B., Nawijn, L., Frijling, J.L., Van Zuiden, M., & Veltman, D.J. (2014). Social support, oxytocin, and PTSD. European Journal of Psychotraumatology, 5, 26513. doi: http://dx.doi.org/10.1007/10.3402/ejpt.v5.26513
69. Pamplona, F.A., Bitencourt, R.M., & Takahashi, R.N. (2008). Short-and long-term effects of cannabinoids on the extinction of contextual fear memory in rats. Neurobiology of Learning and Memory, 90(1), 290-293. doi: http://dx.doi.org/10.1007/10. 1016/j.nlm.2008.04.003
70. Pennington, D.L., Abe, C., Batki, S.L., & Meyerhoff, D.J. (2014). A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder. Psychiatry Research, 224(3), 281-287. doi: http://dx.doi.org/10. 1016/j.pscychresns.2014.09.004
71. Perry, B.D., Giller, E.L., Jr, & Southwick, S.M. (1987). Altered platelet alpha 2-adrenergic binding sites in posttraumatic stress disorder. American Journal of Psychiatry, 144(11), 1511-1512.
72. Petrakis, I.L., Desai, N., Gueorguieva, R., Arias, A., O’Brien, E., Jane, J.S., … Ralevski, E. (2016). Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: A clinical trial. Alcoholism: Clinical and Experimental Research, 40(1), 178-186. doi: http://dx.doi.org/10.1111/acer. 12926
73. Petrakis, I.L., Ralevski, E., Desai, N., Trevisan, L., Gueorguieva, R., Rounsaville, B., … Krystal, J.H. (2012). Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology, 37(4), 996-1004. doi: http://dx. doi.org/10.1038/npp.2011.283
74. Pietrzak, R.H., Gallezot, J.D., Ding, Y.S., Henry, S., Potenza, M.N., Southwick, S.M., … Neumeister, A. (2013). Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus. JAMA Psychiatry, 70(11), 1199-1205. doi: http://dx.doi.org/10.1001/jamapsychiatry.2013.399
75. Pietrzak, R.H., Goldstein, R.B., Southwick, S.M., & Grant, B.F. (2011). Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: Results from wave 2 of the National Epidemiologic Survey on alcohol and related conditions. Journal of Anxiety Disorders, 25(3), 456-465. doi: http://dx.doi.org/10.1016/j.janxdis.2010.11.010
76. Pitman, R.K., Rasmusson, A.M., Koenen, K.C., Shin, L.M., Orr, S.P., Gilbertson, M.W., … Liberzon, I. (2012). Biological studies of posttraumatic stress disorder. Natural Reviews Neuroscience, 13(11), 769-787. doi: http://dx.doi.org/10.1038/nrn3339
77. Pollack, M.H., Jensen, J.E., Simon, N.M., Kaufman, R.E., & Renshaw, P.F. (2008). High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: Response to treatment with levetiracetam. Progress in Neuropsychopharmacology and Biology Psychiatry, 32(3), 739-743. doi: http://dx.doi.org/10.1016/j.pnpbp.2007.11.023
78. Ramboz, S., Oosting, R., Amara, D.A., Kung, H.F., Blier, P., Mendelsohn, M., … Hen, R. (1998). Serotonin receptor 1A knockout: An animal model of anxiety-related disorder. Proceedings of National Academy of Sciences USA, 95(24), 14476-14481.
79. Raskind, M.A., Peterson, K., Williams, T., Hoff, D.J., Hart, K., Holmes, H., … Peskind, E.R. (2013). A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. American Journal of Psychiatry, 170(9), 1003-1010. doi: http://dx.doi.org/10.1176/appi.ajp.2013.12081133
80. Rogan, M.T., Staubli, U.V., & LeDoux, J.E. (1997). Fear conditioning induces associative long-term potentiation in the amygdala. Nature, 390(6660), 604-607. doi: http://dx.doi.org/10.1038/37601
81. Roozendaal, B., Barsegyan, A., & Lee, S. (2008). Adrenal stress hormones, amygdala activation, and memory for emotionally arousing experiences. Progress in Brain Research, 167, 79-97. doi: http://dx.doi.org/10.1016/S0079-6123(07)67006-X
82. Rothbaum, B.O., Price, M., Jovanovic, T., Norrholm, S.D., Gerardi, M., Dunlop, B., … Ressler, K.J. (2014). A randomized, doubleblind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. American Journal of Psychiatry, 171(6), 640-648. doi: http://dx.doi.org/10.1176/appi.ajp.2014.13121625
83. Sabban, E.L., Alaluf, L.G., & Serova, L.I. (2015). Potential of neuropeptide Y for preventing or treating posttraumatic stress disorder. Neuropeptides, 56, 19-24. doi: http://dx.doi.org/10. 1016/j.npep.2015.11.004
84. Sari, Y. (2004). Serotonin1B receptors: From protein to physiological function and behavior. Neuroscience and Biobehavioral Reviews, 28(6), 565-582. doi: http://dx.doi.org/10.1016/j. neubiorev.2004.08.008
85. Saxe, G., Stoddard, F., Courtney, D., Cunningham, K., Chawla, N., Sheridan, R., … King, L. (2001). Relationship between acute morphine and the course of PTSD in children with burns. Journal of American Academy of Child and Adolescent Psychiatry, 40(8), 915-921. doi: http://dx.doi.org/10.1097/00004583-200108000-00013
86. Schonenberg, M., Reichwald, U., Domes, G., Badke, A., & Hautzinger, M. (2005). Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims. Psychopharmacology (Berl), 182(3), 420-425. doi: http://dx.doi.org/10. 1007/s00213-005-0094-4
87. Schonenberg, M., Reichwald, U., Domes, G., Badke, A., & Hautzinger, M. (2008). Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims. Journal of Psychopharmacology, 22(5), 493-497. doi: http://dx.doi.org/10.1177/0269881107082481
88. Seal, K.H., Metzler, T.J., Gima, K.S., Bertenthal, D., Maguen, S., & Marmar, C.R. (2009). Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002-2008. American Journal of Public Health, 99(9), 1651-1658. doi: http://dx.doi.org/10.2105/AJPH.2008.150284
89. Silva, A.P., Xapelli, S., Grouzmann, E., & Cavadas, C. (2005). The putative neuroprotective role of neuropeptide Y in the central nervous system. Current Drug Targets and CNS Neurological Disorders, 4(4), 331-347.
90. Southwick, S.M., Bremner, J.D., Rasmusson, A., Morgan, C.A., 3rd, Arnsten, A., & Charney, D.S. (1999). Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biological Psychiatry, 46(9), 1192-1204.
91. Southwick, S.M., Krystal, J.H., Bremner, J.D., Morgan, C.A., 3rd, Nicolaou, A.L., Nagy, L.M., … Charney, D.S. (1997). Noradrenergic and serotonergic function in posttraumatic stress disorder. Archives of General Psychiatry, 54(8), 749-758.
92. Southwick, S.M., Morgan, C.A., 3rd, Bremner, A.D., Grillon, C.G., Krystal, J.H., Nagy, L.M., … Charney, D.S. (1997). Noradrenergic alterations in posttraumatic stress disorder. Annals of the New York Academy of Sciences, 821, 125-141.
93. Sullivan, G.M., Ogden, R.T., Huang, Y.Y., Oquendo, M.A., Mann, J.J., & Parsey, R.V. (2013). Higher in vivo serotonin-1a binding in posttraumatic stress disorder: A PET study with [11C]WAY-100635. Depression and Anxiety, 30(3), 197-206. doi: http://dx. doi.org/10.1002/da.22019
94. Taylor, F.B., Martin, P., Thompson, C., Williams, J., Mellman, T.A., Gross, C., … Raskind, M.A. (2008). Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: A placebo-controlled study. Biological Psychiatry, 63(6), 629-632. doi: http://dx.doi. org/10.1016/j.biopsych.2007.07.001
95. van Minnen, A., Arntz, A., & Keijsers, G.P. (2002). Prolonged exposure in patients with chronic PTSD: Predictors of treatment outcome and dropout. Behavioral Research and Therapeutics, 40(4), 439-457.
96. Varvel, S.A., Wise, L.E., Niyuhire, F., Cravatt, B.F., & Lichtman, A.H. (2007). Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. Neuropsychopharmacology, 32(5), 1032-1041. doi: http://dx.doi.org/10.1038/sj.npp.1301224
97. Viola, J., Ditzler, T., Batzer, W., Harazin, J., Adams, D., Lettich, L., … Berigan, T. (1997). Pharmacological management of posttraumatic stress disorder: Clinical summary of a five-year retrospective study, 1990-1995. Military Medicine, 162(9), 616-619.
98. Wilkinson, S.T., Yarnell, S., Radhakrishnan, R., Ball, S.A., & D’Souza, D.C. (2016). Marijuana legalization: Impact on physicians and public health. Annual Review of Medicine, 67, 453-466. doi: http://dx.doi.org/10.1146/annurev-med-050214-013454
99. Yarnell, S. (2015). The use of medicinal marijuana for posttraumatic stress disorder: A review of the current literature. The Primary Care Companion for CNS Disorders, 17(3). doi: http://dx.doi. org/10.4088/PCC.15r01786
100. Yeh, M.S., Mari, J.J., Costa, M.C., Andreoli, S.B., Bressan, R.A., & Mello, M.F. (2011). A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neuroscience and Therapeutics, 17(5), 305-310. doi: http://dx.doi.org/10.1111/j.1755-5949.2010.00188.x
101. Young, M.B., Andero, R., Ressler, K.J., & Howell, L.L. (2015). 3,4-Methylenedioxymethamphetamine facilitates fear extinction learning. Translational Psychiatry, 5, e634. doi: http://dx.doi. org/10.1038/tp.2015.138
102. Zohar, J., Amital, D., Miodownik, C., Kotler, M., Bleich, A., Lane, R.M., … Austin, C. (2002). Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 22(2), 190-195.